# Strand Life Sciences’ CancerSpot study published in PNAS

2026-11-22T05:37:15+00:00 | Health & Science | Indian Opinion Desk

Corroboration: 2 independent outlets

Strand Life Sciences has published the research behind its CancerSpot multi-cancer early detection test in the Proceedings of the National Academy of Sciences (PNAS). The four-year study used blood samples from 1,480 subjects and involved 43 hospitals across India. The study found that in cancer patients, higher levels of circulating DNA were associated with stronger cancer-related signals, challenging the assumption that immune-cell DNA would dilute tumour contributions. On an independent validation cohort, CancerSpot demonstrated a false positive rate of 1.4 per cent and detected 72 per cent of cancers. Kalkine reports a tissue-of-origin accuracy of about 76 per cent, noted within the context of study design limitations. Strand CEO Ramesh Hariharan said publication in PNAS attests to the rigour of the science. Dr Sewanti Limaye, a co-author, said the priority is translating the discovery into independently validated screening strategies.

## Indian Opinion Analysis

Kalkine's article frames the CancerSpot publication as a preliminary scientific step, foregrounding caveats about clinical adoption and cost, while Express Healthcare leads with the milestone of PNAS publication and the key finding that immune-cell DNA does not dilute tumor signals. Kalkine omits the specificity and sensitivity figures that Express Healthcare reports (1.4% false positive rate, 72% detection), and Express Healthcare does not discuss false-positive trade-offs at population scale. The balanced reading is that peer-reviewed publication confirms scientific validity, but the studies cited report sensitivity and specificity in a research cohort, not in real-world screening. Both sources agree the next step is independent validation and translation to clinical practice, as Dr Limaye states.

## Coverage

Coverage: 2 sources, 2 neutral
- kalkine.co.in (neutral report) <https://www.kalkine.co.in/article/healthcare/strand-life-sciences-cancerspot-early-detection-research-highlights-what-multi-cancer-blood-tests-must-prove>
- expresshealthcare.in (neutral report) <https://www.expresshealthcare.in/news/strand-life-sciences-cancerspot-study-in-pnas-finds-more-dna-in-blood-can-make-cancer-easier-to-detect/455911/>

This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry.

Tags: CancerSpot, PNAS, Strand Life Sciences
Canonical: https://indianopinion.org/strand-life-sciences-cancerspot-study-published-in-pnas/
License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources.
Cite: https://indianopinion.org/strand-life-sciences-cancerspot-study-published-in-pnas/#story-in-brief

Review state: not offered to search indexes, readable and citable here.

How this brief was made: an AI model read the reports linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. Stance labels are editorial classifications of how each outlet framed this story, assigned by the same model, not ratings of the outlets. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/
